Thorsten Braun
Affiliations: | Université Paris Diderot - Paris 7, Paris, Île-de-France, France |
Google:
"Thorsten Braun"Parents
Sign in to add mentor| Guido Kroemer | grad student | 2007 | Université Paris 7 | |
| (L' apoptose dérégulée au cours des syndromes myélodysplasiques) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Berrou J, Dupont M, Djamai H, et al. (2022) Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive () Acute Lymphoblastic Leukemia (ALL). Journal of Clinical Medicine. 11 |
| Pardieu B, Pasanisi J, Ling F, et al. (2022) Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia |
| Djamai H, Berrou J, Dupont M, et al. (2021) Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML). Biomedicines. 9 |
| Sevin M, Debeurme F, Laplane L, et al. (2021) Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML. Blood |
| Djamai H, Berrou J, Dupont M, et al. (2020) Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinase1/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells. Leukemia Research. 100: 106490 |
| Gardin C, Pautas C, Fournier E, et al. (2020) Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results. Blood Advances. 4: 1942-1949 |
| Habault J, Kaci A, Pasquereau-Kotula E, et al. (2020) Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53. Oncoimmunology. 9: 1728871 |
| Kim R, Boissel N, Touzart A, et al. (2020) Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation. Leukemia |
| Garnache-Ottou F, Vidal C, Biichlé S, et al. (2019) How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Advances. 3: 4238-4251 |
| Massé A, Roulin L, Pasanisi J, et al. (2019) BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias. Leukemia Research. 87: 106269 |